CCL2 and myocardial infarction: McDermott D.H., Yang Q., Kathiresan S., Cupples L.A., Massaro J.M.,Keaney J.F., Larson M.G., Vasan R.S., Hirschhorn J.N., O’DonnellC.J., Murphy Ph.M., Benjamin E.J. CCL2 polymorphisms areassociated with serum monocyte chemoattractant protein-1 levelsand myocardial infarction in the Framingham Heart Study.